Skip to main content
Reported segment mix · SEC DERA dimensional facts

THERMO FISHER SCIENTIFIC INC. TMO revenue by segment, product and geography

In its fiscal year ending 2025-12-31, THERMO FISHER SCIENTIFIC INC. reported revenue across 4 business segments; the largest, Laboratory Products And Biopharma Services, was $23.8B, 53.5% of the filed sum (+3.5% against the prior period in the same filing).

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-02-26prior period 2024-12-31 from the same filingView filing
By business segment
Revenue
  • Laboratory Products And Biopharma Services$23.8B
    53.5%
    +3.5% yoy
  • Life Sciences Solutions$8.78B
    19.7%
    +7.6% yoy
  • Analytical Instruments$7.35B
    16.5%
    +1.2% yoy
  • Specialty Diagnostics$4.6B
    10.3%
    +3.5% yoy

Members sum to the consolidated $44.6B for this period.

By product or service
Revenue
  • Product$26B
    share n/a
    +3.7% yoy
  • Consumables$18.7B
    share n/a
    +6.1% yoy
  • Service$18.6B
    share n/a
    +4.2% yoy
  • Instruments$7.3B
    share n/a
    -1.9% yoy

member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.

By geography
Revenue
  • North America$23B
    share n/a
    +2.4% yoy
  • Outside the United States$22.3B
    share n/a
    +5.6% yoy
  • United States$22.2B
    share n/a
    +2.2% yoy
  • Europe$11.8B
    share n/a
    +8.9% yoy
  • Asia Pacific$8.1B
    share n/a
    +1.8% yoy
  • Other Regions$1.6B
    share n/a
    +2.3% yoy

member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.

Latest quarter
Quarter ending 2026-06-3010-Q filed 2026-07-31prior period 2025-06-30 from the same filingView filing
  • Laboratory Products And Biopharma Services$6.65B
    55.5%
    +11.7% yoy
  • Life Sciences Solutions$2.35B
    19.6%
    +11.3% yoy
  • Analytical Instruments$1.8B
    15.0%
    +7.8% yoy
  • Specialty Diagnostics$1.19B
    9.9%
    +6.3% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

About these figures

Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.

Descriptive and educational; not investment advice. Methodology and data lineage.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.

THERMO FISHER SCIENTIFIC INC. (TMO) revenue by segment, product and geography FY2025 | TrendNalysis